Results from the EARLY TAVR trial — the first randomized, controlled FDA pivotal study designed to determine the best ...

Wandercraft announced today that it enrolled the first participants in a clinical trial evaluating its Personal Exoskeleton ...

JenaValve today announced new results from an expanded cohort receiving its Trilogy transcatheter heart valve (THV) system.

MiRus announced that it launched a U.S. multi-center early feasibility study for its Siegel transcatheter heart valve (THV).

Boston Scientific received FDA clearance for its Bolt intravascular lithotripsy (IVL) system, according to the FDA's 510(k) ...

Abbott (NYSE: ABT) today announced data demonstrating substantial, sustained improvements with its TriClip system.

Boston Scientific (NYSE: BSX) announced new study findings demonstrating the superiority of its Farapulse pulsed field ...